The invention relates to the novel compounds of formula (I), wherein D, M, W, X, Y, T, R
1
and R
1
′ are defined as in patent claim 1. The inventive compounds are inhibitors of coagulation factor Xa and can be used in the prophylaxis and/or therapy of thromboembolic diseases and in the treatment of tumors.
本发明涉及式(I)的新型化合物,其中D,M,W,X,Y,T,R1和R1'如专利权要求书1中所定义。这些创新化合物是
凝血因子Xa的
抑制剂,可用于预防和/或治疗血栓性疾病和肿瘤的治疗。